4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0000950142-22-003233
Director bought 500,000 shares at an average $1.03 ($514,905)
From the SEC's structured data for this filing
Trades in this filing
Hurvitz Chaim · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-16 | Purchase : show line 1 in the form | +287,812 | $0.99 | $284,934 | 287,812 | D |
| 2022-11-17 | Purchase : show line 2 in the form | +171,780 | $1.08 | $185,522 | 459,592 | D |
| 2022-11-18 | Purchase : show line 3 in the form | +40,408 | $1.10 | $44,449 | 500,000 | D |
| Open-market purchases · 500,000 sh · avg $1.03 · $514,905 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-10-21 | Grant or award : show line 4 in the form Employee Stock Option | +162,660 | 381,083 | D |
Loading xslF345X03/es220307158_4-hurvitz.xml…